RILMENIDINE

SynDRA canonical compound SYN0002114 — structure-anchored drug synonym record

Clinical phase	Launched
Primary target(s)	ADRA2A
Mechanism of action	Imidazoline receptor agonist
Indication	hypertension
Disease area	cardiology

All known targets

NISCH
ADRA2A
ADRA2C
ADRA1A
ADRA2B
Nisch

Mechanisms of action (all sources)

Adrenergic receptor agonist
Imidazoline receptor agonist
NISCH AGONIST
Nischarin agonist
ADRA2C MODULATOR

Drug classes

Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists
Antihypertensive Agents
Cardiovascular Agents
Neurotransmitter Agents
Peripheral Nervous System Agents
Sympatholytics

ATC classes

C02A · ANTIADRENERGIC AGENTS, CENTRALLY ACTING

Cross-references

PubChem CID: 68712
ChEMBL: CHEMBL289480
DrugBank: DB11738
ChEBI: CHEBI:8862
KEGG: D08482
Wikipedia: Rilmenidine
TTD: D06OFS
LINCS BRD: BRD-K01638814

Synonyms

oxaminozoline
rilmenidene
rilmenidine phosphate
rilmenidine dihydrogen phosphate
Rilmenidina
Hyperium
Rilmenidine phosphate
Rilmenidine dihydrogen phosphate
UNII-59QD64Q32M
EINECS 287-106-2
59QD64Q32M
S 3341-3
4,5-Dihydro-N-(dicyclopropylmethyl)-2-oxazolamine phosphate (1:1)
2-Oxazolamine, 4,5-dihydro-N-(dicyclopropylmethyl)-, phosphate (1:1)
(Dicyclopropylmethyl)(4,5-dihydro-2-oxazolyl)ammonium dihydrogen phosphate
W-104082
2-Oxazolamine, N-(dicyclopropylmethyl)-4,5-dihydro-, phosphate (1:1)
N-(dicyclopropylmethyl)-4,5-dihydrooxazol-2-amine
phosphoric acid
Oxaminozoline
Rilmenidinum
rilmenidina
2-Oxazolamine, N-(dicyclopropylmethyl)-4,5-dihydro-
P67IM25ID8
S-3341
DTXCID1025194
RefChem:179457
C02AC06
s33413
S-3341-3
2-(N-(Dicyclopropylmethyl)amino)oxazoline
N-(Dicyclopropylmethyl)-4,5-dihydrooxazol-2-amine
N-(Dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine
Rilmenidine [INN]
Rilmenidia [Spanish]
Rilmenidinum [Latin]
Oxazolidine, 2-((dicyclopropylmethyl)imino)-
MFCD00865924

Look up RILMENIDINE in the interactive SynDRA portal →